Organogenesis enters $75 million at-the-market equity sales agreement
ORGO•At-the-market equity sales agreement
- Organogenesis entered an at-the-market equity distribution agreement to sell up to $75 million of Class A common stock.
- BTIG, LLC and Citizens JMP Securities will act as sales agents for the offering.
- Shares may be sold from time to time on Nasdaq or other trading markets, subject to company instructions.
- Agents will receive commissions of up to 3% of gross sales proceeds.
